Cover Image

Antimicrobial Resistance in <i>Streptococcus pneumoniae</i> before and after the Introduction of Pneumococcal Conjugate Vaccines in Brazil: A Systematic Review

<i>Streptococcus pneumoniae</i> causes serious illnesses, such as pneumonia, bacteremia, and meningitis, mainly in immunocompromised individuals and those of extreme ages. Currently, pneumococcal conjugate vaccines (PCVs) are the best allies against pneumococcal diseases. In Brazil, the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Patricia Alice Knupp-Pereira (Author), Amanda Seabra Cabral (Author), Ítalo Moraes Dolores (Author), Amanda Beiral da Silva (Author), Helvécio Cardoso Correa Póvoa (Author), Felipe Piedade Gonçalves Neves (Author)
Format:	Book
Published:	MDPI AG, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine
by: Ellie Alexander, et al.
Published: (2008)

Prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in children 7 to 14 years in 2016: A survey before pneumococcal conjugate vaccine introduction in Iran
by: Manoochehr Karami, et al.
Published: (2019)

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines
by: Qian-qian Du, et al.
Published: (2021)

Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine
by: Nivaldo Linares-Pérez, et al.
Published: (2019)

Prevalence of Streptococcus pneumoniae serotype 19A before and after the introduction of the heptavalent conjugate vaccine in Mexico.
by: Gabriela Echániz-Avilés, et al.
Published: (2014)

Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru
by: Theresa J. Ochoa, et al.
Published: (2024)

Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco
by: Idrissa Diawara, et al.
Published: (2017)

Serotype spectrum of <i>S. pneumoniae</i> in children after the introduction of pneumococcal vaccine in Uzbekistan
by: E. A. Shamansurova, et al.
Published: (2024)

Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introduction
by: Shampa Saha, et al.
Published: (2016)

Impacto da vacina conjugada contra Streptococcus pneumoniae em doenças invasivas Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases
by: Lucia Ferro Bricks, et al.
Published: (2006)

Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine
by: Sona Chowdhary, et al.
Published: (2008)

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
by: Kaile Chen, et al.
Published: (2018)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of <i>Streptococcus pneumoniae</i> Causing Invasive Disease in Piedmont, Italy
by: Alessandro Bondi, et al.
Published: (2024)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis
by: Rita Reyburn, MSc, et al.
Published: (2021)

Pneumococcal conjugate vaccine is efficacious and effective in reducing the burden of pneumonia
by: Shabir A Madhi, et al.
Published: (2008)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
by: Diana C. Caceres, et al.
Published: (2018)

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
by: Wei Feifei, et al.
Published: (2005)

Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia
by: Gabriel Carrasquilla, et al.
Published: (2021)

Impact of pneumococcal conjugate vaccine on the carriage density of Streptococcus pneumoniae and Staphylococcus aureus in children living with HIV: a nested case-control study
by: Tila Khan, et al.
Published: (2020)

Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018
by: Tianyan Hu, et al.
Published: (2023)

Post-introduction economic evaluation of pneumococcal conjugate vaccination in Ecuador, Honduras, and Paraguay
by: Dagna O. Constenla

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study
by: Claire von Mollendorf, et al.
Published: (2021)

Nasopharyngeal carriage of Streptococcus pneumoniae among children aged 30 days to <60 months in Beijing and Shenzhen, China (2018-2021) during pneumococcal conjugate vaccine introduction and the coronavirus disease (COVID-19) pandemic
by: Qianqian Du, et al.
Published: (2024)

Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018
by: Tianyan Hu, et al.
Published: (2022)

Antibiotic Resistance of <i>Streptococcus pneumoniae</i> in the Nasopharynx of Healthy Children Less than Five Years Old after the Generalization of Pneumococcal Vaccination in Marrakesh, Morocco
by: Sara Amari, et al.
Published: (2023)

Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine
by: Nicholas T. K. D. Dayie, et al.
Published: (2019)

Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination
by: Mackenzie Grant, et al.
Published: (2009)

Surveillance of bacterial meningitis in an Angolan pediatric hospital after the introduction of pneumococcal conjugate vaccines
by: Suvi Urtti, et al.
Published: (2019)

Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022
by: Anithasree Athiyaman, et al.
Published: (2023)

Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco
by: Mark A. Fletcher, et al.
Published: (2021)

Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco
by: Nada Bennani Mechita, et al.
Published: (2020)

Pneumococcal Diseases in Colombia: Epidemiological Analysis Before and During the Universal Children Immunization against Streptococcus pneumoniae in the Light of a Vaccine Change in 2022
by: Carlos Torres-Martínez
Published: (2024)

A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine
by: Idrissa Diawara, et al.
Published: (2017)

Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7)
by: Javier Nieto Guevara, et al.
Published: (2013)

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial
by: Lu-Lu Pan, et al.
Published: (2022)